schemaVersion:

Form C: Filer Information

Filer CIK:
0001957114 
Filer CCC:
XXXXXXXX 
Period:

12-31-2022 

Is this a LIVE or TEST Filing?Radio button checked LIVE Radio button not checked TEST
Is this an electronic copy of an official filing submitted in paper format in connection with a hardship exemption?Checkbox not checked
Would you like a Return Copy?Checkbox not checked

Submission Contact Information

Name:
 
Phone Number:
 
Contact E-Mail Address:
 
Notify via Filing Website only?Checkbox not checked

Form C: Issuer Information

Issuer Information

Name of Issuer:

iMetabolic Biopharma Corporation 

Legal Status of Issuer:

Form:

Corporation 

Jurisdiction of Incorporation/Organization:

NEVADA  

Date of Incorporation/Organization:

11-17-2017 

Physical Address of Issuer:

Address 1:

2155 E Conference Dr STE 115 

City:

Tempe 

State/Country:

ARIZONA  

Mailing Zip/Postal Code:

85284-2604 

Website of Issuer:

https://imbiopharma.com/ 

Is there a Co-issuer? Radio button not checked Yes Radio button checked No

Form C: Annual Report Disclosure Requirements

Annual Report Disclosure Requirements

Current Number of Employees:

4 

Total Assets Most Recent Fiscal Year-end:

4601.00 

Total Assets Prior Fiscal Year-end:

64248.00 

Cash and Cash Equivalents Most Recent Fiscal Year-end:

4601.00 

Cash and Cash Equivalents Prior Fiscal Year-end:

62248.00 

Accounts Receivable Most Recent Fiscal Year-end:

0.00 

Accounts Receivable Prior Fiscal Year-end:

0.00 

Short-term Debt Most Recent Fiscal Year-end:

0.00 

Short-term Debt Prior Fiscal Year-end:

0.00 

Long-term Debt Most Recent Fiscal Year-end:

161025.00 

Long-term Debt Prior Fiscal Year-end:

155471.00 

Revenue/Sales Most Recent Fiscal Year-end:

0.00 

Revenue/Sales Prior Fiscal Year-end:

0.00 

Cost of Goods Sold Most Recent Fiscal Year-end:

0.00 

Cost of Goods Sold Prior Fiscal Year-end:

0.00 

Taxes Paid Most Recent Fiscal Year-end:

0.00 

Taxes Paid Prior Fiscal Year-end:

0.00 

Net Income Most Recent Fiscal Year-end:

-94513.00 

Net Income Prior Fiscal Year-end:

-63745.00 

Form C: Signature

Signature

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), the issuer certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form C and has duly caused this Form to be signed on its behalf by the duly authorized undersigned.

Issuer:

iMetabolic Biopharma Corporation 

Signature:

Urban Austin Kiernan 

Title:

Chairman, President, Treasurer and Principle Financial Officer 

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:

Urban Austin Kiernan 

Title:

Chairman, President, Treasurer and Principle Financial Officer 

Date:

04-26-2023 

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:

Jeffrey D. Zimmerman 

Title:

Secretary and General Counsel 

Date:

04-26-2023